Pediatric Psoriasis Treatment - Global and China Top Players Market Share and Ranking 2023
According to the Latest Research Report,, the global market for Pediatric Psoriasis Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
This report studies and analyses global Pediatric Psoriasis Treatment status and future trends, helps the client to determine the Pediatric Psoriasis Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pediatric Psoriasis Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pediatric Psoriasis Treatment market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Pediatric Psoriasis Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Pediatric Psoriasis Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Pediatric Psoriasis Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pediatric Psoriasis Treatment key producing regions, capacity, production, and year over year growth
(6) Pediatric Psoriasis Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
AbbVie
Amgen
Johnson and Johnson
Novartis AG
Eli Lilly and Company
AstraZeneca
Celgene Corporation
UCB
Merck
Boehringer Ingelheim
LEO Pharma
Qingdao Vland Biotech
Yunnan Botanee Bio-Technology
Furen Group
Jiangsu Kanion Pharmaceutical
Tianjin Pacific Pharmaceutical
Market segment by Type, covers
Topical Treatment
Systemic Treatment
Market segment by Application, can be divided into
Psoriasis Vulgaris
Pustular Psoriasis
Erythrodermic Psoriasis
Arthropathic Psoriasis
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Pediatric Psoriasis Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pediatric Psoriasis Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Pediatric Psoriasis Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Pediatric Psoriasis Treatment, percent & CAGR, 2018-2029
Chapter 5: Pediatric Psoriasis Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pediatric Psoriasis Treatment Definition
1.2 Global Pediatric Psoriasis Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Pediatric Psoriasis Treatment Market Size，2018-2029
1.2.2 By Sales Quantity, Global Pediatric Psoriasis Treatment Market Size，2018-2029
1.2.3 Global Pediatric Psoriasis Treatment Average Selling Price (ASP)，2018-2029
1.3 China Pediatric Psoriasis Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Pediatric Psoriasis Treatment Market Size，2018-2029
1.3.2 By Sales Quantity, China Pediatric Psoriasis Treatment Market Size，2018-2029
1.3.3 China Pediatric Psoriasis Treatment Average Selling Price (ASP)， 2018-2029
1.4 Share of China Pediatric Psoriasis Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pediatric Psoriasis Treatment Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Pediatric Psoriasis Treatment Market Share in Global, 2018-2029
1.4.3 Pediatric Psoriasis Treatment Market Size: China VS Global, 2018-2029
1.5 Pediatric Psoriasis Treatment Market Dynamics
1.5.1 Pediatric Psoriasis Treatment Market Drivers
1.5.2 Pediatric Psoriasis Treatment Market Restraints
1.5.3 Pediatric Psoriasis Treatment Industry Trends
1.5.4 Pediatric Psoriasis Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pediatric Psoriasis Treatment, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Pediatric Psoriasis Treatment, Global Market Share by Company, 2018-2023
2.3 Pediatric Psoriasis Treatment Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Pediatric Psoriasis Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pediatric Psoriasis Treatment Concentration Ratio
2.6 Global Pediatric Psoriasis Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Pediatric Psoriasis Treatment Manufacturers Product Type
2.8 Head Office and Pediatric Psoriasis Treatment Production Site of Key Manufacturer
2.9 Pediatric Psoriasis Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pediatric Psoriasis Treatment, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Pediatric Psoriasis Treatment, China Market Share by Company, 2018-2023
3.3 China Pediatric Psoriasis Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pediatric Psoriasis Treatment Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Pediatric Psoriasis Treatment Capacity by Region
4.3 Global Pediatric Psoriasis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Pediatric Psoriasis Treatment Production by Region, 2018-2029
4.5 Global Pediatric Psoriasis Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pediatric Psoriasis Treatment Industry Chain
5.2 Pediatric Psoriasis Treatment Upstream Analysis
5.2.1 Pediatric Psoriasis Treatment Core Raw Materials
5.2.2 Main Manufacturers of Pediatric Psoriasis Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pediatric Psoriasis Treatment Production Mode
5.6 Pediatric Psoriasis Treatment Procurement Model
5.7 Pediatric Psoriasis Treatment Industry Sales Model and Sales Channels
5.7.1 Pediatric Psoriasis Treatment Sales Model
5.7.2 Pediatric Psoriasis Treatment Typical Distributors
6 Sights by Type
6.1 Pediatric Psoriasis Treatment Classification
6.1.1 Topical Treatment
6.1.2 Systemic Treatment
6.2 By Type, Global Pediatric Psoriasis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029
6.4 By Type, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029
6.5 By Type, Global Pediatric Psoriasis Treatment Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Pediatric Psoriasis Treatment Segment by Application
7.1.1 Psoriasis Vulgaris
7.1.2 Pustular Psoriasis
7.1.3 Erythrodermic Psoriasis
7.1.4 Arthropathic Psoriasis
7.2 By Application, Global Pediatric Psoriasis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029
7.4 By Application, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029
7.5 By Application, Global Pediatric Psoriasis Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pediatric Psoriasis Treatment Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029
8.3 By Region, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Pediatric Psoriasis Treatment & Forecasts, 2018-2029
8.4.2 By Country, North America Pediatric Psoriasis Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Pediatric Psoriasis Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pediatric Psoriasis Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pediatric Psoriasis Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pediatric Psoriasis Treatment Market Size Market Share
8.7 South America
8.7.1 South America Pediatric Psoriasis Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pediatric Psoriasis Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pediatric Psoriasis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029
9.3 By Country, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Pediatric Psoriasis Treatment Market Size, 2018-2029
9.4.2 By Type, U.S. Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pediatric Psoriasis Treatment Market Size, 2018-2029
9.5.2 By Type, Europe Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Pediatric Psoriasis Treatment Market Size, 2018-2029
9.6.2 By Type, China Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pediatric Psoriasis Treatment Market Size, 2018-2029
9.7.2 By Type, Japan Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pediatric Psoriasis Treatment Market Size, 2018-2029
9.8.2 By Type, South Korea Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pediatric Psoriasis Treatment Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Pediatric Psoriasis Treatment Market Size, 2018-2029
9.10.2 By Type, India Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pediatric Psoriasis Treatment Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbbVie
10.1.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
10.1.2 AbbVie Pediatric Psoriasis Treatment Models, Specifications, and Application
10.1.3 AbbVie Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbbVie Company Profile and Main Business
10.1.5 AbbVie Recent Developments
10.2 Amgen
10.2.1 Amgen Company Information, Head Office, Market Area, and Industry Position
10.2.2 Amgen Pediatric Psoriasis Treatment Models, Specifications, and Application
10.2.3 Amgen Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Amgen Company Profile and Main Business
10.2.5 Amgen Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Company Information, Head Office, Market Area, and Industry Position
10.3.2 Johnson and Johnson Pediatric Psoriasis Treatment Models, Specifications, and Application
10.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Johnson and Johnson Company Profile and Main Business
10.3.5 Johnson and Johnson Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.4.2 Novartis AG Pediatric Psoriasis Treatment Models, Specifications, and Application
10.4.3 Novartis AG Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Novartis AG Company Profile and Main Business
10.4.5 Novartis AG Recent Developments
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information, Head Office, Market Area, and Industry Position
10.5.2 Eli Lilly and Company Pediatric Psoriasis Treatment Models, Specifications, and Application
10.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Eli Lilly and Company Company Profile and Main Business
10.5.5 Eli Lilly and Company Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.6.2 AstraZeneca Pediatric Psoriasis Treatment Models, Specifications, and Application
10.6.3 AstraZeneca Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 AstraZeneca Company Profile and Main Business
10.6.5 AstraZeneca Recent Developments
10.7 Celgene Corporation
10.7.1 Celgene Corporation Company Information, Head Office, Market Area, and Industry Position
10.7.2 Celgene Corporation Pediatric Psoriasis Treatment Models, Specifications, and Application
10.7.3 Celgene Corporation Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Celgene Corporation Company Profile and Main Business
10.7.5 Celgene Corporation Recent Developments
10.8 UCB
10.8.1 UCB Company Information, Head Office, Market Area, and Industry Position
10.8.2 UCB Pediatric Psoriasis Treatment Models, Specifications, and Application
10.8.3 UCB Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 UCB Company Profile and Main Business
10.8.5 UCB Recent Developments
10.9 Merck
10.9.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.9.2 Merck Pediatric Psoriasis Treatment Models, Specifications, and Application
10.9.3 Merck Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Merck Company Profile and Main Business
10.9.5 Merck Recent Developments
10.10 Boehringer Ingelheim
10.10.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.10.2 Boehringer Ingelheim Pediatric Psoriasis Treatment Models, Specifications, and Application
10.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Boehringer Ingelheim Company Profile and Main Business
10.10.5 Boehringer Ingelheim Recent Developments
10.11 LEO Pharma
10.11.1 LEO Pharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 LEO Pharma Pediatric Psoriasis Treatment Models, Specifications, and Application
10.11.3 LEO Pharma Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 LEO Pharma Company Profile and Main Business
10.11.5 LEO Pharma Recent Developments
10.12 Qingdao Vland Biotech
10.12.1 Qingdao Vland Biotech Company Information, Head Office, Market Area, and Industry Position
10.12.2 Qingdao Vland Biotech Pediatric Psoriasis Treatment Models, Specifications, and Application
10.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Qingdao Vland Biotech Company Profile and Main Business
10.12.5 Qingdao Vland Biotech Recent Developments
10.13 Yunnan Botanee Bio-Technology
10.13.1 Yunnan Botanee Bio-Technology Company Information, Head Office, Market Area, and Industry Position
10.13.2 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Models, Specifications, and Application
10.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Yunnan Botanee Bio-Technology Company Profile and Main Business
10.13.5 Yunnan Botanee Bio-Technology Recent Developments
10.14 Furen Group
10.14.1 Furen Group Company Information, Head Office, Market Area, and Industry Position
10.14.2 Furen Group Pediatric Psoriasis Treatment Models, Specifications, and Application
10.14.3 Furen Group Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Furen Group Company Profile and Main Business
10.14.5 Furen Group Recent Developments
10.15 Jiangsu Kanion Pharmaceutical
10.15.1 Jiangsu Kanion Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Models, Specifications, and Application
10.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Jiangsu Kanion Pharmaceutical Company Profile and Main Business
10.15.5 Jiangsu Kanion Pharmaceutical Recent Developments
10.16 Tianjin Pacific Pharmaceutical
10.16.1 Tianjin Pacific Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Models, Specifications, and Application
10.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Tianjin Pacific Pharmaceutical Company Profile and Main Business
10.16.5 Tianjin Pacific Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pediatric Psoriasis Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pediatric Psoriasis Treatment Market Restraints
Table 3. Pediatric Psoriasis Treatment Market Trends
Table 4. Pediatric Psoriasis Treatment Industry Policy
Table 5. Global Pediatric Psoriasis Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Pediatric Psoriasis Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Pediatric Psoriasis Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Pediatric Psoriasis Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Pediatric Psoriasis Treatment Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Pediatric Psoriasis Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pediatric Psoriasis Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Pediatric Psoriasis Treatment Manufacturers Product Type
Table 13. Head Office and Pediatric Psoriasis Treatment Production Site of Key Manufacturer
Table 14. Pediatric Psoriasis Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Pediatric Psoriasis Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Pediatric Psoriasis Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Pediatric Psoriasis Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Pediatric Psoriasis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Pediatric Psoriasis Treatment Production by Region, 2018-2023, (K Units)
Table 20. Global Pediatric Psoriasis Treatment Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Pediatric Psoriasis Treatment Upstream (Raw Materials)
Table 22. Global Pediatric Psoriasis Treatment Typical Customers
Table 23. Pediatric Psoriasis Treatment Typical Distributors
Table 24. By Type, Global Pediatric Psoriasis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Pediatric Psoriasis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Pediatric Psoriasis Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Pediatric Psoriasis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Pediatric Psoriasis Treatment Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Pediatric Psoriasis Treatment Sales Quantity Market Share, 2018-2029
Table 34. AbbVie Company Information, Head Office, Market Area, and Industry Position
Table 35. AbbVie Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 36. AbbVie Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. AbbVie Company Profile and Main Business
Table 38. AbbVie Recent Developments
Table 39. Amgen Company Information, Head Office, Market Area, and Industry Position
Table 40. Amgen Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 41. Amgen Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Amgen Company Profile and Main Business
Table 43. Amgen Recent Developments
Table 44. Johnson and Johnson Company Information, Head Office, Market Area, and Industry Position
Table 45. Johnson and Johnson Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 46. Johnson and Johnson Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Johnson and Johnson Company Profile and Main Business
Table 48. Johnson and Johnson Recent Developments
Table 49. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 50. Novartis AG Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 51. Novartis AG Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis AG Company Profile and Main Business
Table 53. Novartis AG Recent Developments
Table 54. Eli Lilly and Company Company Information, Head Office, Market Area, and Industry Position
Table 55. Eli Lilly and Company Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 56. Eli Lilly and Company Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Eli Lilly and Company Company Profile and Main Business
Table 58. Eli Lilly and Company Recent Developments
Table 59. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 60. AstraZeneca Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 61. AstraZeneca Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. AstraZeneca Company Profile and Main Business
Table 63. AstraZeneca Recent Developments
Table 64. Celgene Corporation Company Information, Head Office, Market Area, and Industry Position
Table 65. Celgene Corporation Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 66. Celgene Corporation Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Celgene Corporation Company Profile and Main Business
Table 68. Celgene Corporation Recent Developments
Table 69. UCB Company Information, Head Office, Market Area, and Industry Position
Table 70. UCB Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 71. UCB Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. UCB Company Profile and Main Business
Table 73. UCB Recent Developments
Table 74. Merck Company Information, Head Office, Market Area, and Industry Position
Table 75. Merck Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 76. Merck Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Merck Company Profile and Main Business
Table 78. Merck Recent Developments
Table 79. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 80. Boehringer Ingelheim Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 81. Boehringer Ingelheim Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Boehringer Ingelheim Company Profile and Main Business
Table 83. Boehringer Ingelheim Recent Developments
Table 84. LEO Pharma Company Information, Head Office, Market Area, and Industry Position
Table 85. LEO Pharma Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 86. LEO Pharma Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. LEO Pharma Company Profile and Main Business
Table 88. LEO Pharma Recent Developments
Table 89. Qingdao Vland Biotech Company Information, Head Office, Market Area, and Industry Position
Table 90. Qingdao Vland Biotech Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 91. Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Qingdao Vland Biotech Company Profile and Main Business
Table 93. Qingdao Vland Biotech Recent Developments
Table 94. Yunnan Botanee Bio-Technology Company Information, Head Office, Market Area, and Industry Position
Table 95. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 96. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Yunnan Botanee Bio-Technology Company Profile and Main Business
Table 98. Yunnan Botanee Bio-Technology Recent Developments
Table 99. Furen Group Company Information, Head Office, Market Area, and Industry Position
Table 100. Furen Group Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 101. Furen Group Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Furen Group Company Profile and Main Business
Table 103. Furen Group Recent Developments
Table 104. Jiangsu Kanion Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 106. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jiangsu Kanion Pharmaceutical Company Profile and Main Business
Table 108. Jiangsu Kanion Pharmaceutical Recent Developments
Table 109. Tianjin Pacific Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Models, Specifications, and Application
Table 111. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Tianjin Pacific Pharmaceutical Company Profile and Main Business
Table 113. Tianjin Pacific Pharmaceutical Recent Developments
List of Figures
Figure 1. Pediatric Psoriasis Treatment Picture
Figure 2. Global Pediatric Psoriasis Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Pediatric Psoriasis Treatment Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Pediatric Psoriasis Treatment Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Pediatric Psoriasis Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Pediatric Psoriasis Treatment Sales Quantity (K Units) & (2018-2029)
Figure 7. China Pediatric Psoriasis Treatment Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Pediatric Psoriasis Treatment Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Pediatric Psoriasis Treatment Market Share of Global, 2018-2029
Figure 10. Global Pediatric Psoriasis Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Pediatric Psoriasis Treatment Key Participants, Market Share, 2022
Figure 12. Global Pediatric Psoriasis Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Pediatric Psoriasis Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Pediatric Psoriasis Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 15. Pediatric Psoriasis Treatment Industry Chain
Figure 16. Pediatric Psoriasis Treatment Procurement Model
Figure 17. Pediatric Psoriasis Treatment Sales Model
Figure 18. Pediatric Psoriasis Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Topical Treatment
Figure 20. Systemic Treatment
Figure 21. By Type, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Pediatric Psoriasis Treatment Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Pediatric Psoriasis Treatment Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Pediatric Psoriasis Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Psoriasis Vulgaris
Figure 27. Pustular Psoriasis
Figure 28. Erythrodermic Psoriasis
Figure 29. Arthropathic Psoriasis
Figure 30. By Application, Global Pediatric Psoriasis Treatment Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Pediatric Psoriasis Treatment Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Pediatric Psoriasis Treatment Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Pediatric Psoriasis Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Pediatric Psoriasis Treatment Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Pediatric Psoriasis Treatment Sales Quantity Market Share, 2018-2029
Figure 37. North America Pediatric Psoriasis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Pediatric Psoriasis Treatment Consumption Value Market Share, 2022
Figure 39. Europe Pediatric Psoriasis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Pediatric Psoriasis Treatment Consumption Value Market Share, 2022
Figure 41. Asia Pacific Pediatric Psoriasis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Pediatric Psoriasis Treatment Consumption Value Market Share, 2022
Figure 43. South America Pediatric Psoriasis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Pediatric Psoriasis Treatment Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Pediatric Psoriasis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|